Novo Nordisk Pharma, Inc.
(NNPI) Products
Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
This is a premixed insulin analog indicated to improve glycemic control in patients with diabetes mellitus. Insulin Aspart Protamine and Insulin Aspart Injectable Suspension Mix 70/30 is an Unbranded Biologic of Novolog® Mix 70/30, a Novo Nordisk Inc. product.
This is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. Insulin Aspart is an Unbranded Biologic of Novolog®, a Novo Nordisk Inc. product.
This is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Insulin Degludec is an Unbranded Biologic of Tresiba®, a Novo Nordisk Inc. product.
Find more information
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
